Image: Adobe Stock
Sudden reopening would jeopardize progress made thus far
This is Day 50. It feels like Day 500.
A new coronavirus, which technically isnt even alive, has outwitted us. The COVID-19 pandemic has paralyzed the state and the nation, vanquished our economy and killed 40,000 people in the U.S. including 235 in North Carolina and another 131,000 worldwide, all of whom were loved by someone.
How do we gain the upper hand over an invisible pathogen that moves stealthily and with no regard for its target?
On April 21, three doctors affiliated with Duke University discussed the prospects for reopening the nation, the inconsistent federal response, and clarified the nuances of testing, both for coronavirus antibodies and active COVID-19 infections. The conversation was held via videoconference with the media.
Dr. Michael Dee Gunn is an immunology professor at the Duke University School of Medicine. From a medical perspective, people advocating a premature opening of the economy, Gunn said, are advocating that every person in this country become infected with coronavirus.
Reopeners are primarily far-right conservatives inspired by the likes of Infowarss Alex Jones and other discredited conspiracy theorists. They have staged numerous demonstrations nationwide to protest not only states stay-at-home orders but also science.
Yet the publics impatience is expected. No one has shown them the light at the end of the tunnel, Gunn said. It would be very beneficial if at the federal level someone said, This is the schedule were on, and give people an expectation to work with. As it is now, [the message] changes every day. No wonder everyone is frustrated.
The Trump administration has whipsawed the public with conflicting messages that are driven by politics, not science. Even though he had been briefed to the contrary months earlier, President Trump said in early March that the virus was no worse than the flu, and would soon disappear. Instead of disappearing, over the next six weeks 40,000 people in the U.S. died and in the hardest-hit areas, the entire medical system was overwhelmed with cases.
Despite the presidents assurances that plenty of testing and medical equipment were available, there have been severe shortages of both, resulting in a Lord of the Flies-like competition among states for ventilators, masks and protective gowns.
The sideshow continued in late March, when Trump said the country would open by Easter. Then under pressure from public health officials, Trump postponed the date until May 1, which experts said was still too soon. Shortly afterward, Trump said he had total authority to reopen the country, an assertion that has no constitutional basis. Then he backtracked, and put the onus on state governors to decide how to lift their stay-at-home orders.
But Trump soon undermined the states efforts; within a day via Twitter he incited demonstrations against the governors in several states where stay-at-home orders are in place: Minnesota, Michigan and Virginia.
Like a virus, those demonstrations spread to other states, including North Carolina. U.S. Rep. Dan Bishop of the ninth congressional district and State Sen. Vickie Sawyer, both Republicans, are among the elected officials who attended the protests. Gov. Roy Cooper has said as long as protesters remain six feet apart the standard recommendation for social distancing the demonstrations are allowed.
Dr. Thomas Denny, chief operating officer of the Duke Human Vaccine Institute, said the country should be reopened gradually or risk higher rates of infection and death. Im concerned that in this rush were forgetting everything weve learned, Denny said.
I know there are a lot of people who have lost their jobs. They may be motivated by that, and I understand, but we need to address the economics on a national level and take this slower. There could be rings of containment and rings of loosening, based on health data, Denny said.
While the reopeners are seizing their moment in the spotlight, most people in America are quietly and nervously trying to avoid becoming infected. A recent Washington Post-University of Maryland poll found that of 1,013 people surveyed, with 57% saying they are very or somewhat worried about becoming infected and seriously ill from the coronavirus. Multiple polls have found that Americans are more worried about reopening the economy too quickly than too slowly.
What the federal government needs to do right now is to come up with a coherent plan, Gunn said. The American people are willing to sacrifice for the common good. The government needs to say, Were asking you to buy into it. Thats who were going to get control of this virus.
Testing free-for-all must be reined in, better coordinated
Gaining control of the coronavirus will require widespread testing: One type to determine if someone has an active infection and should be treated and isolated; another to detect antibodies in the blood, which indicate the person has been infected at some point in the past.
The Centers for Disease Control and Prevention initially shipped thousands of flawed test kits that had been made in a contaminated lab. Subsequently the FDA fast-tracked millions of antibody testing kits some that had never been verified to county health departments, only to learn later that many of them were faulty.
Its been a free-for-all, Gunn said. Every company that could put out a test, did. Theres not been the quality control that this needs. We need a national coordination.
Test kits, enzymes, chemicals, reagents, protective gear for health care workers administering the tests: All of these must be manufactured en masse, quickly but precisely.
Its a complicated test, Gunn said. Its not instant. We need to develop tests that are sensitive enough so that we have rapid results like pregnancy tests.
Once reliable antibody tests are available, first responders and health workers should be the first to receive them, Denny said. Hopefully if we have another surge well have a better understanding of the risk those individuals have.
Its nearly certain that even in states where the number of reported cases is declining, there will be another surge in the fall or sooner, depending on how quickly the stay-at-home orders are lifted.
A robust tracking system, including painstakingly tracing an infected persons contacts could help contain smaller outbreaks, Gunn said. Its like a forest fire. Once its under control, its a matter of managing the hotspots.
And there will be hotspots. Since the virus is new, scientists dont yet fully understand how it behaves. For example, simply having antibodies for the virus doesnt mean you are immune to it, Gunn said.
And after people recover, its unclear who is immune and how long people shed the virus. What risk that poses is not well understood, said Dr. Chris Woods, co-director of the Center for Global Health at Duke University and chief of the infectious diseases division Durham VA Medical Center. Were still learning a lot about how its transmitted, and whether or not there is a change in the virus that makes it more transmissible or more or less virulent over time.
An estimated 7,000 people in North Carolina have tested positive for COVID-19. That is likely an undercount because of the testing shortage. Moreover, many people with mild or moderate symptoms dont go to the doctor so their cases arent counted. But even if 1 million North Carolinians have had the disease in some form, thats still only 10% of the state population. That means 90% of North Carolinians would be vulnerable.
We need to understand the background rate of immunity, Woods said. Without the benefit of herd immunity which occurs when large numbers of people have become immune to the disease and provide indirect protection for people who havent yet had it we would expect periodic outbreaks of disease but we would have public health tools to contain it.
While the federal government, especially the CDC, which has been nearly invisible throughout the crisis, needs to provide funding and technical support, the burden of containment will likely fall to the states and county health departments.
It will be costly and it will take a lot of people to execute these plans, Denny said. The local health departments are very important to identify who are most at risk like low-income people, who typically see more health problems and then work out a plan. Its going to take time.
This story has been corrected to show that 7,000 people in North Carolina have tested positive for the coronavirus.
Continue reading here:
Duke health experts call for patience, testing, improved federal coordination in pandemic battle - ncpolicywatch.com
- The future of immunology - Johnson & Johnson - March 5th, 2025 [March 5th, 2025]
- Immunotherapys Sweet Future: Wrapping up AACR IO 2025 With Glyco-immunology - American Association for Cancer Research (AACR) - March 5th, 2025 [March 5th, 2025]
- J&J receives three CHMP recommendations for immunology and oncology indications - PMLiVE - March 5th, 2025 [March 5th, 2025]
- Greater Austin Allergy, Asthma & Immunology now open in the Shops at the Galleria - Community Impact - March 5th, 2025 [March 5th, 2025]
- As dengue spreads, researchers discover a clue to fighting the virus - La Jolla Institute for Immunology - February 25th, 2025 [February 25th, 2025]
- Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma and Immunology and World Allergy Organization Joint Congress - Business... - February 25th, 2025 [February 25th, 2025]
- PhD candidate Jesse Lehman receives Kirschstein Award to study immunology - UMass Medical School - February 25th, 2025 [February 25th, 2025]
- Cross-priming in cancer immunology and immunotherapy - Nature.com - February 3rd, 2025 [February 3rd, 2025]
- Sanofi Happy To Spend To Hit Immunology Top Spot - News & Insights - February 3rd, 2025 [February 3rd, 2025]
- The Converging Therapeutic Landscape of Oncology and Immunology: Accelerating Innovation in Biotech - MedCity News - January 23rd, 2025 [January 23rd, 2025]
- VC Firm Foresite Capital Dishes on Biotech Innovation in China, Opportunities in Immunology - MedCity News - January 23rd, 2025 [January 23rd, 2025]
- Immunology - The Scientist - January 23rd, 2025 [January 23rd, 2025]
- Immunology Startup Ouro Sets Out With $120M for Drugs That Reset the Immune System - MedCity News - January 15th, 2025 [January 15th, 2025]
- Scipher Medicine and Atropos Health Partner to Accelerate Precision Medicine and Expand the Immunology Multimodal Network - Business Wire - December 23rd, 2024 [December 23rd, 2024]
- AbbVie to expand immunology pipeline with $200m Nimble Therapeutics acquisition - PMLiVE - December 23rd, 2024 [December 23rd, 2024]
- Sir Gustav Nossal Professor of Immunology to honour giant of Australian science - Walter and Eliza Hall Institute of Medical Research - December 9th, 2024 [December 9th, 2024]
- Research Assistant in Immunology - Surrey, United Kingdom job with UNIVERSITY OF SURREY | 384335 - Times Higher Education - November 28th, 2024 [November 28th, 2024]
- Reflecting on Pioneering organoids and 3D cell cultures for animal and human health - British Society for Immunology | - November 28th, 2024 [November 28th, 2024]
- Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET - Business Wire - November 20th, 2024 [November 20th, 2024]
- TRexBio Announces $84 Million Series B Financing to Advance Pipeline of First-in-Class Immunology Programs into Clinical Development - Business Wire - November 20th, 2024 [November 20th, 2024]
- Discovering Solutions for Long COVID: A T-Cell Immunology Breakthrough - Infection Control Today - November 20th, 2024 [November 20th, 2024]
- Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET IPH6501 - The Bakersfield Californian - November 20th, 2024 [November 20th, 2024]
- Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of... - November 20th, 2024 [November 20th, 2024]
- What it's like in allergy and immunology: Shadowing Dr. Fraser - American Medical Association - November 12th, 2024 [November 12th, 2024]
- Dr. Naba Sharif Elected President of the New Jersey Allergy Asthma and Immunology Society - Newswire - November 12th, 2024 [November 12th, 2024]
- Department of Microbiology and Immunology Named a National Milestones Program - Stony Brook News - October 26th, 2024 [October 26th, 2024]
- Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting - businesswire.com - October 26th, 2024 [October 26th, 2024]
- Remembering immunology educator, researcher Tom McDonald, PhD - University of Nebraska Medical Center - October 13th, 2024 [October 13th, 2024]
- Systems immunology approaches to study T cells in health and disease - Nature.com - October 13th, 2024 [October 13th, 2024]
- Leading the charge to discover answers in immunology - The University of Arizona - October 2nd, 2024 [October 2nd, 2024]
- New mouse models offer valuable window into COVID-19 infection - La Jolla Institute for Immunology - October 2nd, 2024 [October 2nd, 2024]
- Wide-Moat AbbVie Poised for Growth, Driven by Innovation in Immunology Beyond Humira - Morningstar - October 2nd, 2024 [October 2nd, 2024]
- Lilly's immunology unit scores another FDA nod with eczema treatment Ebglyss - FiercePharma - September 23rd, 2024 [September 23rd, 2024]
- Huang Named Head Of Pathology And Immunology - Mirage News - September 15th, 2024 [September 15th, 2024]
- Huang named head of pathology & immunology - Washington University School of Medicine in St. Louis - September 15th, 2024 [September 15th, 2024]
- Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit - Yahoo Finance - September 15th, 2024 [September 15th, 2024]
- Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit - StockTitan - September 15th, 2024 [September 15th, 2024]
- UCLA receives $120 million from Alya and Gary Michelson for new California Institute for Immunology and Immunotherapy - UCLA Newsroom - September 2nd, 2024 [September 2nd, 2024]
- Boosting vaccines for the elderly with 'hyperactivators' - Boston Children's Answers - Boston Children's Discoveries - June 27th, 2024 [June 27th, 2024]
- Immunologists Want You to Know These Dust Mite Allergy Facts - Yahoo Lifestyle UK - June 27th, 2024 [June 27th, 2024]
- How Ragon Institute's new building aids its mission Harvard Gazette - Harvard Gazette - June 27th, 2024 [June 27th, 2024]
- Insights into CRS and NPs: Visual and Bibliometric Analysis - Physician's Weekly - June 27th, 2024 [June 27th, 2024]
- Biogen joins immunology wave with $1.15 billion acquisition of HI-Bio - STAT - May 24th, 2024 [May 24th, 2024]
- Biogen Buys Desired Growth In Immunology With $1.15bn Hi-Bio Deal - Scrip - May 24th, 2024 [May 24th, 2024]
- Biogen Boosts Immunology Portfolio with $1.8 Billion Acquisition of HI-Bio - BioPharm International - May 24th, 2024 [May 24th, 2024]
- Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395 - Yahoo Finance - May 24th, 2024 [May 24th, 2024]
- Biogen to expand immunology and rare disease portfolio with $1.8bn HI-Bio acquisition - PMLiVE - May 24th, 2024 [May 24th, 2024]
- Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress - Business Wire - May 24th, 2024 [May 24th, 2024]
- Biogen to buy Human Immunology Biosciences in deal worth up to $1.8B - MM+M Online - May 24th, 2024 [May 24th, 2024]
- COVID-19 Re-Vaccinations Elicit Neutralizing Antibodies Against Future Variants - Technology Networks - May 24th, 2024 [May 24th, 2024]
- HIV Vaccine Candidate Induces Broadly Neutralizing Antibodies in Humans - Technology Networks - May 24th, 2024 [May 24th, 2024]
- Pasteur Fiocruz Center on Immunology and Immunotherapy is inaugurated in Cear - Fiocruz - May 24th, 2024 [May 24th, 2024]
- Biogen to buy Human Immunology Biosciences in up to $1.8 billion deal - Marketscreener.com - May 24th, 2024 [May 24th, 2024]
- Fellow Focus in Four: Marat Kribis, MD, Rheumatology, Allergy and Immunology - Yale School of Medicine - April 15th, 2024 [April 15th, 2024]
- Long COVID Can Now Be Detected in the Blood - Technology Networks - April 15th, 2024 [April 15th, 2024]
- Rimjhim Agarwal selected as Major Symposium speaker at the American Association of Immunologists ... - La Jolla Institute for Immunology - March 29th, 2024 [March 29th, 2024]
- Seeking new horizons: Where innovators find opportunities in a fast-changing immunology landscape - IQVIA - March 29th, 2024 [March 29th, 2024]
- Researchers identify new way to inhibit immune cells that drive allergic asthma - EurekAlert - March 29th, 2024 [March 29th, 2024]
- Innovation in Oncology and Cancer Immunology Research - Boehringer Ingelheim - March 29th, 2024 [March 29th, 2024]
- Measles outbreaks show the risk of under-vaccination | News | Harvard T.H. Chan School of Public Health - HSPH News - March 29th, 2024 [March 29th, 2024]
- Immunology-oncology ELISA Kits Market to Witness a Healthy Growth by 2030 - WhaTech - March 29th, 2024 [March 29th, 2024]
- Spring Allergy Season Is Getting Worse. Here's What to Know. - The New York Times - March 29th, 2024 [March 29th, 2024]
- Multiple sclerosis has distinct subtypes, study finds, pointing to different treatments - STAT - March 29th, 2024 [March 29th, 2024]
- Researchers identify viable vaccine targets for hepatitis C infections - News-Medical.Net - March 29th, 2024 [March 29th, 2024]
- Three research projects awarded funding from the Immunology Institute Pilot Project program - University of Alabama at Birmingham - February 29th, 2024 [February 29th, 2024]
- Deal Watch: AbbVie Adds To Immunology Pipeline Through Deal With OSE - Scrip - February 29th, 2024 [February 29th, 2024]
- AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific Biologics for Oncology ... - PR Newswire - February 29th, 2024 [February 29th, 2024]
- Integrating single-cell multi-omics and prior biological knowledge for a functional characterization of the immune system - Nature.com - February 29th, 2024 [February 29th, 2024]
- Renowned immunologist and four-decade UAB researcher Max Cooper, M.D., will deliver this year's Marx Lecture - University of Alabama at Birmingham - February 29th, 2024 [February 29th, 2024]
- Inactivation of TGF- signaling in CAR-T cells | Cellular & Molecular Immunology - Nature.com - February 29th, 2024 [February 29th, 2024]
- Babies use their immune system differently but efficiently | Cornell Chronicle - Cornell Chronicle - February 29th, 2024 [February 29th, 2024]
- Antibody reduces allergic reactions to multiple foods in NIH clinical trial - National Institutes of Health (NIH) (.gov) - February 29th, 2024 [February 29th, 2024]
- Mestag Therapeutics Enlists Leading Cancer Biology and Immunology Advisors to Support Clinical Development of its ... - GlobeNewswire - February 21st, 2024 [February 21st, 2024]
- Theratechnologies announces publication in Frontiers in Immunology on TH1902 - TipRanks.com - TipRanks - February 21st, 2024 [February 21st, 2024]
- Smoking has long-term effects on the immune system - Institut Pasteur - February 21st, 2024 [February 21st, 2024]
- Spring Allergies Attack More Than Just Your Nose - ACAAI Public Website - American College of Allergy Asthma and Immunology - February 21st, 2024 [February 21st, 2024]
- Theratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel ... - GlobeNewswire - February 21st, 2024 [February 21st, 2024]
- Shikhar Mehrotra named co-leader of Cancer Biology and Immunology research program at MUSC Hollings - The Cancer Letter - January 27th, 2024 [January 27th, 2024]
- Gut Microbiome Benefits of Breast Milk Revealed in Mouse Study - Technology Networks - January 27th, 2024 [January 27th, 2024]
- Research on Immunological Diseases Launches with Hungarian Participation - Hungary Today - January 27th, 2024 [January 27th, 2024]